Close Menu

University of Manchester

The circulating tumor cell-based classifier had an overall accuracy of 89 percent for small-cell lung cancer patients, the researchers reported.

The Stoller Biomarker Discovery Centre, funded by the UK's Medical Research Council, recently opened to develop mass spec-based research for varied diseases.

The company will use proceeds from the placement to conduct clinical trials on its Parsortix CTC system, which has been adopted by Cancer Research UK's Mancherster Institute.

Researchers at the annual meeting of the American Association for Cancer Research discussed their efforts to use genomics to protect patients from radiotherapy toxicity.

The funds will support the development of bioinformatics tools for use in clinical trials to provide more personalized healthcare for cancer patients

The partners received £30,000 (about $46,000) in funding from the BBSRC to support their metabolomics data-sharing and analyses activities.

The results provide early evidence for the ability of haplotypes in the HLA-DRB1 gene to predict outcome and drug response, which will have to be further replicated.

Cancer-ID is a newly created consortium tasked with validating blood-based biomarkers, such as CTC, cfDNA, and miRNA to bring liquid biopsies into the clinic.

NEW YORK (GenomeWeb) – The University of Manchester today said that it has been awarded £24 million ($38.5 million), including funding for omics-directed projects, from the UK government.

NEW YORK (GenomeWeb News) – A pair of genome sequencing studies published online yesterday in Nature Genetics is providing insights into the biology of parasitic whipworms, interactions with their hosts, and potential applications for treating inflammatory disease.

Pages

Researchers have sequenced the genome of the depth-dwelling giant squid.

Prosecutors have charged a former Drexel University professor with theft for allegedly spending federal grant money on adult entertainment and other unrelated expenses, according to the Philadelphia Inquirer.

 

Chris Collins, a former US representative, has been sentenced to more than two years in prison in an insider trading case involving an Australian biotechnology firm, the New York Times reports.

In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.